Evidence map›Paper›PMID 31844987›Full record

ReviewSurgery today2020

Aortoesophageal fistula: review of trends in the last decade.

Shinsuke Takeno, Hiroto Ishii, Atsushi Nanashima, Kunihide Nakamura

Abstract readReview
PubMed Publisher
In one paragraph

Review in Surgery today, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Staged open surgical repair of an aortic esophageal fistula in the setting of an aortic dissection.Journal of vascular surgery cases and innovative techniques · 2026
    Article
  11. Article
  12. Article
  13. Fatal Aortoesophageal Fistula after Esophagectomy for Esophageal Cancer: A Single-Center Retrospective Analysis.Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shinsuke TakenoDepartment of Surgery, University of Miyazaki Hospital, Kihara 5200, Kiyotake-cho, Miyazaki City, Miyazaki, 889-1692, Japan. shinsuke_takeno@med.miyazaki-u.ac.jp.
Hiroto IshiiDepartment of Surgery, University of Miyazaki Hospital, Kihara 5200, Kiyotake-cho, Miyazaki City, Miyazaki, 889-1692, Japan.
Atsushi NanashimaDepartment of Surgery, University of Miyazaki Hospital, Kihara 5200, Kiyotake-cho, Miyazaki City, Miyazaki, 889-1692, Japan.
Kunihide NakamuraDepartment of Surgery, University of Miyazaki Hospital, Kihara 5200, Kiyotake-cho, Miyazaki City, Miyazaki, 889-1692, Japan.
University of Miyazaki · JPUniversity of Miyazaki Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reviewed articles on aortoesophageal fistula (AEF) published between January, 2009 and December, 2018. Postoperative aortic disease was the most common cause of AEF, followed by primary aortic aneurysm, bone ingestion, and thoracic cancer. Thoracic endovascular aortic repair (TEVAR) was the most common initial therapy for primary aortic disease, rather than graft replacement. Secondary AEF developed between 1 and 268 months, and between 1 and 11 months after the initial therapy for aortic disease and thoracic cancer, respectively. TEVAR trended to be preferred over surgery for aortic lesions because of its minimal invasiveness and certified hemostasis. In contrast, esophagectomy was preferred for esophageal lesions to remove the infectious source. A combination of surgery for the aorta (TEVAR, graft replacement or repair) and esophagus (esophagectomy, esophageal stent or repair) was usually adopted. Each graft replacement or esophagectomy was associated with a favorable prognosis for aortic or esophageal surgery, and the combination of graft replacement and esophagectomy generally improved the prognosis remarkably. Antibiotic therapy was given to 65 patients, with 20 receiving multiple antibiotics aimed at strong effects and the type of antibiotic described as broad-spectrum in 29 patients. Meropenem, vancomycin, and fluconazole were the most popular antibiotics used to prevent graft or stent infection. In conclusion, graft replacement and esophagectomy can achieve a favorable prognosis for patients with AEF, but strong, broad-spectrum antibiotic therapy might be required to prevent sepsis after surgery.

Indexed as

AdolescentAdultAnti-Bacterial AgentsAorta, ThoracicAortic DiseasesBlood Vessel Prosthesis ImplantationEndovascular ProceduresEsophageal FistulaEsophagectomyEsophagusFemaleHumansMaleMiddle AgedPostoperative ComplicationsSepsisAnti-Bacterial AgentsAortoesophageal fistulaOutcomeStentSurgery

Identifiers

PMID31844987
OpenAlexW2995019342

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.